CAITLYN SALLEY: Open Payments
NPI 1689346611 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,675 in 57 payments from 20 companies in 2025. Trend: 2023 $319 · 2024 $688 · 2025 $1,675
Food & beverage: $1,675
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $177 |
| Edwards Lifesciences Corporation | 1 | $148 |
| Boston Scientific Corporation | 2 | $144 |
| Abbott Laboratories | 3 | $128 |
| BridgeBio Pharma, Inc. | 5 | $124 |
| BIOTRONIK INC. | 1 | $124 |
| SCPHARMACEUTICALS INC. | 5 | $120 |
| Novo Nordisk Inc | 4 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Alnylam Pharmaceuticals Inc. | 5 | $100 |
Products named: SAPIEN 3 Ultra RESILIA, WATCHMAN FLX, Attruby, AMVIA EDGE, FUROSCIX, Wegovy, CARDIOMEMS, LEQVIO.
Industry payments across SC — which companies pay providers there.
